Catch the Latest Buzz: Weekly News Release Highlights

$SONTK Sono-Tek announced a significant uptick in sales by 40% and a remarkable surge in net income by 525% for the initial quarter of fiscal year 2025. The company has also provided sales projections for the second quarter of fiscal year 2025, anticipating continuous growth in sales throughout the fiscal year https://prismmediawire.com/sono-tek-reports-40-increase-in-sales-and-525-increase-in-net-income-for-first-quarter-fiscal-2025/

$SMCE SMC Entertainment, Inc. (OTC: SMCE), a dynamic incubator firm specializing in acquiring and aiding established financial services and technology (Fintech) companies, is excited to announce the retirement of an additional $436,884 of debt through consulting fees and management conversion of accumulated earnings (referred to as the "Debt"). This Debt repayment will be evident in the third-quarter 2024 financial records of the Company https://prismmediawire.com/smc-announces-retirement-of-additional-436884-of-debt/ 

$OCX In the most recent episode of the renowned podcast MedTech Gurus, which delves into cutting-edge medical technology, the focus was on an interview with Josh Riggs, the CEO of Oncocyte Corporation (NASDAQ: OCX), discussing how to seize the current opportunities https://prismmediawire.com/medtech-gurus-podcast-features-oncocyte-ceo-josh-riggs-in-take-advantage-of-the-moment-episode/

$SKYX SKYX (NASDAQ: SKYX) has unveiled an innovative recessed light that is globally patented, providing a smart Plug & Play solution. This product is poised to take the Global Recessed Light Market by storm as SKYX broadens its reach. The light has patents in important markets like the U.S., China, Canada, Hong Kong, and Mexico and is configured for safe and easy installation. Controlled through SKYX's App, Voice Control, or Phone, it's compatible with popular voice assistants like Siri, Alexa, Google Home, and Samsung. With a massive patent portfolio, SKYX is enhancing its value in industries such as safety, smart home, AI, electrical, lighting, and ceiling fans https://prismmediawire.com/skyx-announces-production-of-its-new-global-patented-advanced-smart-plug-play-recessed-light/

$BIEI Premier Graphene, Inc. provided graphene suspension samples to a global materials provider through their partner, HGI Industrial Technologies. This enhances the sustainability and strength of concrete, resulting in faster curing times, increased durability, reduced maintenance, and significant cost savings on concrete materials https://prismmediawire.com/premier-graphene-inc-ships-advanced-graphene-suspension-samples-to-global-leader-in-essential-materials/

$WAVE ANEW MEDICAL is at the forefront of innovation in the medical field by spearheading the development of cutting-edge Patented Klotho Gene Therapy to address the complex challenges posed by Neurodegenerative Disorders. This groundbreaking therapy represents a significant leap forward in the treatment of conditions such as Alzheimer's disease, Parkinson's disease, and Huntington's disease.

Neurodegenerative disorders are debilitating conditions that affect millions of individuals worldwide, leading to a progressive decline in cognitive function and motor skills. By targeting the Klotho gene, ANEW MEDICAL's therapy aims to restore balance and function to the brain, potentially slowing down or even reversing the effects of these devastating diseases.

With the aging population on the rise, the need for effective treatments for neurodegenerative disorders has never been more urgent. ANEW MEDICAL's Advanced Patented Klotho Gene Therapy offers hope to patients and their families, providing a promising avenue for improving quality of life and extending longevity.

Through rigorous research and clinical trials, ANEW MEDICAL is paving the way for a new era in neurodegenerative disease treatment. The potential impact of this innovative therapy cannot be overstated, as it has the potential to revolutionize the field of medicine and offer new possibilities for those affected by these debilitating conditions. https://prismmediawire.com/anew-medical-to-advance-patented-klotho-gene-therapy-for-neurodegenerative-disorder-treatments/

$RMSL REMSleep Holdings Inc. has successfully secured regulatory clearance under the 510(K) pathway for their latest product. This milestone signifies a significant achievement for the company, as it paves the way for the product to enter the market and reach consumers.

The 510(K) clearance process is a rigorous evaluation conducted by the FDA to ensure that the product is safe and effective for its intended use. By obtaining this clearance, REMSleep Holdings Inc. has demonstrated that its product meets all the necessary regulatory requirements and standards.

This achievement will not only boost the company's reputation in the industry but also instill confidence in consumers regarding the safety and efficacy of the product. With regulatory hurdles cleared, REMSleep Holdings Inc. can now focus on marketing and distribution strategies to bring its product to a broader audience.

In the competitive landscape of the healthcare industry, obtaining 510(K) clearance is a crucial step toward commercial success. It opens up new opportunities for growth and expansion, allowing companies to tap into larger markets and increase their market share. REMSleep Holdings Inc.'s successful clearance is a testament to its commitment to innovation and quality in the medical device sector. https://prismmediawire.com/remsleep-holdings-inc-receives-510k-clearance-on-product/

$SSII SSi Mantra Expands Global Footprint: Nepal's First Surgical Robot Set to Transform Healthcare Sector https://prismmediawire.com/ssi-mantra-expands-global-footprint-nepals-first-surgical-robot-set-to-transform-healthcare-sector/

$AMS American Shared Hospital Services has entered a Joint Venture Agreement for a state-of-the-art Gamma Knife facility in Guadalajara, Mexico. This partnership aims to offer advanced medical services in the region, meeting the increasing demand for specialized treatments.

The facility will provide cutting-edge technology and expertise in Gamma Knife procedures, ensuring access to top-notch healthcare options. By expanding its reach and building international relationships, the company is dedicated to enhancing healthcare capabilities globally.

The introduction of this facility will benefit the local community and contribute to advancing medical technology in Mexico, aligning with the company's mission to improve access to high-quality healthcare services and establish itself as a leader in advanced medical treatments.

This agreement signifies the start of a new era in healthcare collaboration and innovation, with the facility poised to become a center of excellence in the region for treating neurological conditions https://prismmediawire.com/american-shared-hospital-services-announces-signing-of-joint-venture-agreement-for-gamma-knife-facility-in-guadalajara-mexico/

$NBCO Neon Bloom has taken a new direction under fresh leadership, with a notable shift in the company's trajectory following the decision to sell off Bazelet™. This strategic move signifies a significant transformation in the organization's course of action. By divesting Bazelet™, Neon Bloom is poised to realign its focus and resources towards new opportunities and growth areas.

The sale of Bazelet™ reflects a calculated decision to streamline operations and optimize the company's portfolio. This change in leadership and strategic direction is expected to bring about positive changes and enhance the overall competitiveness of Neon Bloom in the market. As a result, stakeholders are anticipating a period of transition and evolution for the company https://prismmediawire.com/neon-bloom-changes-course-with-new-leadership-and-divestment-of-bazelet/

$BSEM BioStem Technologies Inc., a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care has received approval from the IRB for a clinical study on AmnioWrap2™ (AW2) in diabetic foot ulcers (DFU), a placental-derived allograft product.

The company aims to advance AW2 in the diabetic foot ulcer market with expanded Payer Insurance Coverage. Diabetic foot ulcers are a significant issue for individuals with diabetes mellitus, causing a strain on healthcare systems with estimated annual treatment costs in the billions in the United States https://prismmediawire.com/biostem-receives-institutional-review-board-irb-approval-to-advance-a-clinical-study-evaluating-amniowrap2-in-diabetic-foot-ulcers/

$AVAI Avant Technologies, Inc., a leader in AI technology, is introducing advanced data centers with immersible AI supercomputer servers to meet the demands of the AI and big data industry. The company aims to provide enhanced data capabilities, personalized services, and cost-effective solutions while addressing sustainability concerns with smaller environmental footprints and reduced energy consumption https://prismmediawire.com/avant-technologies-to-meet-unmet-needs-in-ai-industry-while-addressing-sustainability-concerns/